Miami, FL April 10, 2012—Modern Veterinary Therapeutics, LLC announces that the Veterinary Drugs Directorate (VDD) has approved RESPIPULMIN^TM (Clenbuterol hydrochloride syrup) in Canada for the treatment of respiratory disease in horses. RESPIPULMIN^TM is presented in a 355 mL bottle of syrup containing 0.025 mg of clenbuterol hydrochloride per mL. RESPIPULMIN^TM syrup is an orally administered beta-2 agonist for the management of airway obstruction. Bronchodilators relieve the airway obstruction associated with inflammatory airway disease and they work most effectively when combined with allergen and dust avoidance or corticosteroid administration. “Modern Veterinary Therapeutics, LLC is pleased to report this new approval in Canada demonstrating our commitment to become a strategic and trusted partner to veterinarians in Canada” said Dr. Cuong Tu Ba, President and founder of Modenr Veterinary Therapeutics, LLC.